RT Journal Article
SR Electronic
T1 Alterations in Brain Morphology by MRI in Adults with Neurofibromatosis 1
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2019.12.19.19015255
DO 10.1101/2019.12.19.19015255
A1 Wang, Su
A1 Mautner, Victor-Felix
A1 Buchert, Ralph
A1 Flibotte, Stephane
A1 Suppa, Per
A1 Friedman, Jan M.
A1 Heran, Manraj K. S.
YR 2021
UL http://medrxiv.org/content/early/2021/07/02/2019.12.19.19015255.abstract
AB Objective To characterize alterations in brain morphology by MRI in adults with neurofibromatosis 1 (NF1).Methods Planar (2D) MRI measurements of 29 intracranial structures were compared in 389 adults with NF1 and 112 age- and sex-matched unaffected control subjects. The 2D measurements were correlated to volumetric (3D) brain measurements for 99 of the adults with NF1.A subset of adults with NF1 (n = 70) was also assessed for clinical severity of NF1 features and neurological problems and received psychometric testing for attention deficits and IQ. Correlation analyses were performed between principal components of the intracranial measurements and clinical and psychometric features of these patients.Results Four of nine corpus callosum measurements were significantly greater in adults with NF1 than in sex- and age-matched controls. All seven brainstem measurements were significantly greater in adults with NF1 than in controls. Increased corpus callosum and brainstem 2D morphology were correlated with increased total white matter volume among the NF1 patients. No robust correlations were observed between the 2D size of these structures and clinical or neuropsychometric assessments.Interpretation Our findings are consistent with the hypothesis that dysregulation of brain myelin production is an important manifestation of NF1 in adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe would like to thank Sofia Granstroem who analysed the neuropsychometric data. We are grateful to the Bundesverband Neurofibromatose organization for funding this project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymous data is available for appropriate research purposes through V.F. Mautner, MD.